SPONSOR
Ascendis Pharma A/S
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: HypoparathyroidismTurner SyndromeShort Stature Homeobox Gene MutationIdiopathic Short StatureSmall for Gestational Age at Delivery
Ascendis Pharma A/S is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Hypoparathyroidism, Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ascendis Pharma A/S
How many clinical trials has Ascendis Pharma A/S sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Ascendis Pharma A/S, of which 2 are actively recruiting participants. These trials cover conditions including Hypoparathyroidism, Turner Syndrome, Short Stature Homeobox Gene Mutation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ascendis Pharma A/S research focus on?
Ascendis Pharma A/S clinical trials span Hypoparathyroidism, Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at Delivery. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ascendis Pharma A/S clinical trial?
To participate in a Ascendis Pharma A/S trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ascendis Pharma A/S trials with current recruitment status updated daily.
Clinical Trials by Ascendis Pharma A/S
NCT07345494
Recruiting
A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
Hypoparathyroidism
NCT07221851 Phase 3
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Turner Syndrome
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology